Compare PLSE & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLSE | LAZ |
|---|---|---|
| Founded | 2014 | 1848 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.4B |
| IPO Year | 2015 | 2004 |
| Metric | PLSE | LAZ |
|---|---|---|
| Price | $52.32 | $40.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $67.67 | $43.38 |
| AVG Volume (30 Days) | 362.6K | ★ 1.5M |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 4.95% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.20 |
| Revenue | N/A | ★ $3,186,466,000.00 |
| Revenue This Year | $480.71 | $5.98 |
| Revenue Next Year | $177.98 | $19.40 |
| P/E Ratio | ★ N/A | $33.66 |
| Revenue Growth | N/A | ★ 1.48 |
| 52 Week Low | $12.56 | $34.13 |
| 52 Week High | $58.94 | $58.75 |
| Indicator | PLSE | LAZ |
|---|---|---|
| Relative Strength Index (RSI) | 49.27 | 56.54 |
| Support Level | $49.66 | $39.46 |
| Resistance Level | $56.54 | $45.71 |
| Average True Range (ATR) | 4.03 | 1.57 |
| MACD | -0.08 | 0.30 |
| Stochastic Oscillator | 24.10 | 53.71 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.